News Detail
Amsterdam, 22 June 2023: The European Medicines Agency (EMA) has ramped up its scrutiny of GLP-1 treatments, raising a safety signal&......
View Details
Source : Fierce Biotech
European Medicines Agency (EMA)
GLP-1 treatments
potential risk
diabetes and obesity drugs
cause cancer
Eli Lilly
AstraZeneca
Sanofi
Ozempic
Wegovy
Mounjaro
Pharmacovigilance Risk Assessment Committee (PRAC)
semaglutide
liraglutide
Related News
- Illegally selling medicines in a under construction house in Bhopal, seized 22 type of drugs (06-10-2024)
- Gilead Sciences agrees to license new HIV prevention drug to 120 countries (06-10-2024)
- Five sentenced to 10 year rigorous imprisonment for smuggling Ketamine (06-10-2024)
- Treated by fake doctor without MBBS who was working as RMO for five years (06-10-2024)
- 'Create rare diseases fund': Delhi HC to Centre (06-10-2024)
- 10th pass Ramkishore of Bandikui became doctor by putting photo on the documents of Ramkishore of Dungarpur (06-10-2024)
- Fake call centres selling Viagra, duping people in loan fraud busted, 36 arrested (05-10-2024)
- SHEOHAR: Raid on illegal nursing home and medical shop, medicines worth Rs 5 lakh seized (05-10-2024)
- Iron tablets prime target of illegal med producers (05-10-2024)
- DEA Issues Warning About Illegal Online Pharmacies (05-10-2024)